Molecular Partners (MOLN) News Today → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free MOLN Stock Alerts $3.65 -0.23 (-5.93%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLife Science Cares Launches in Switzerlandglobenewswire.com - April 19 at 11:12 AMWe Think Molecular Partners (VTX:MOLN) Needs To Drive Business Growth Carefullyfinance.yahoo.com - April 18 at 2:20 AMMolecular Partners Announces All Board Proposals Approved at the Annual General Meetingglobenewswire.com - April 17 at 11:12 AMmarketbeat.com - April 12 at 3:20 PMmarketbeat.com - April 12 at 2:45 PMBeyond Benign, MilliporeSigma partner on green chemistrybizjournals.com - April 4 at 7:47 PMmarketbeat.com - April 3 at 9:44 AMMolecular Partners Publishes Invitation to Annual General Meeting 2024globenewswire.com - March 26 at 9:26 AMLeerink Partners Keeps Their Hold Rating on Molecular Partners (MOLN)markets.businessinsider.com - March 21 at 9:32 AMMolecular Partners Reports Corporate Highlights From Q4 2023 and Key Financials for Full Year 2023globenewswire.com - March 14 at 4:00 PMMolecular Partners AG (spons. ADRs) hosts conference call for investorsmarkets.businessinsider.com - March 13 at 1:23 PMThe past three years for Molecular Partners (VTX:MOLN) investors has not been profitablefinance.yahoo.com - March 13 at 8:22 AMMolecular Partners wins dismissal of securities lawsuituk.investing.com - March 2 at 10:41 PMMolecular Partners Announces Dismissal of Class Action Lawsuitglobenewswire.com - March 1 at 4:17 PMMolecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentationsglobenewswire.com - March 1 at 4:00 PMMolecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 7 at 4:40 PMMolecular Partners, Orano to collaborate on RDT therapies for cancermsn.com - January 5 at 5:30 PMmarketbeat.com - January 3 at 11:58 AMMolecular Partners AG (6ML0.MU)ca.finance.yahoo.com - December 31 at 7:59 PMMolecular Partners AG (NASDAQ:MOLN) Short Interest Down 39.2% in Decembermarketbeat.com - December 29 at 8:14 AMMolecular Partners Presents Positive Initial Data from First Four Dosing Cohorts of Ongoing Phase 1/2a Trial of MP0533 for Patients with Relapsed/Refractory AML and AML/MDS at ASH Annual Meetingfinance.yahoo.com - December 10 at 2:06 PMMolecular Partners AG ADR MOLNmorningstar.com - November 11 at 8:05 AMMolecular Partners to Present Initial Data from Ongoing Phase 1/2a Trial of MP0533 for Patients with Relapsed/Refractory AML and AML/MDS at the 65th ASH Annual Meeting and Expositionfinance.yahoo.com - November 2 at 7:43 AMMolecular Partners to Participate in the TD Cowen 7th Annual Fall Oncology Innovation Summitfinance.yahoo.com - November 1 at 5:39 AMShareholders in Molecular Partners (VTX:MOLN) are in the red if they invested five years agofinance.yahoo.com - October 5 at 5:03 AMMolecular Partners Reports H1 2023 Corporate Highlights and Financialsfinance.yahoo.com - August 24 at 5:16 PMOwning 32% shares,hedge funds owners seem interested in Molecular Partners AG (VTX:MOLN),finance.yahoo.com - July 13 at 8:54 AMMolecular Partners to Present on its Radio DARPin Therapy (RDT) Platform at SNMMI 2023finance.yahoo.com - June 27 at 5:50 AMMolecular Partners to Present on its Radio DARPin Therapy (RDT) Platform at SNMMI 2023finance.yahoo.com - June 27 at 5:50 AMMolecular Partners to Present at The TD Cowen Radiopharmaceutical Innovation Summitfinance.yahoo.com - June 19 at 12:55 PMCompanies Like Molecular Partners (VTX:MOLN) Are In A Position To Invest In Growthfinance.yahoo.com - June 2 at 12:26 PMMolecular Partners to Present Positive Data from Ongoing Phase 1 Trial of MP0317 (FAP X CD40) Monotherapy in Patients with Advanced Solid Tumors at the 2023 ASCO Annual Meetingfinance.yahoo.com - May 25 at 6:39 PMSVB Securities Sticks to Their Hold Rating for Molecular Partners (MOLN)markets.businessinsider.com - May 15 at 9:44 AMMolecular Partners AG (NASDAQ:MOLN) Short Interest Updatemarketbeat.com - May 1 at 1:07 AMMolecular Partners to Present Additional Preclinical Data Supporting the Company's Radio DARPin Therapy Platform at AACRmarketwatch.com - April 15 at 9:17 AMMolecular Partners to Present Additional Preclinical Data Supporting the Company’s Radio DARPin Therapy Platform at AACRfinance.yahoo.com - April 14 at 4:36 AMMolecular Partners AG (NASDAQ:MOLN) Q4 2022 Earnings Call Transcriptfinance.yahoo.com - March 13 at 2:27 AMMolecular Partners GAAP EPS of $3.54 misses by $0.52, revenue of $189.6M misses by $5.3Mmsn.com - March 9 at 5:19 PMMolecular Partners Reports Corporate Highlights From Q4 2022 and Key Financials for Full Year 2022finance.yahoo.com - March 9 at 5:19 PMPotential Earnings Have Rated Ambrx Biopharma a Moderate Buy (MOLN)marketbeat.com - March 7 at 11:51 AMSVB Securities Keeps Their Hold Rating on Molecular Partners (MOLN)markets.businessinsider.com - February 22 at 1:52 PMAlphaCentric Advisors LLC Purchases Shares of 32,500 Molecular Partners AG (NASDAQ:MOLN)marketbeat.com - February 3 at 10:44 AMMolecular Partners Initiates Clinical Study of Trispecific Candidate MP0533 for the Treatment of Acute Myeloid Leukemiafinance.yahoo.com - January 16 at 7:55 AMHedge funds own 28% of Molecular Partners AG (VTX:MOLN) shares but individual investors control 41% of the companyfinance.yahoo.com - January 12 at 8:44 AMMolecular Partners Provides Updates at 41st Annual JPM Healthcare Conferencefinance.yahoo.com - January 8 at 3:15 PMMolecular Partners to Present at 41st Annual JP Morgan Healthcare Conference and Swiss Investor Conferencesfinance.yahoo.com - December 30 at 2:45 AMMolecular Partners AG (NASDAQ:MOLN) Short Interest Up 9.7% in Novembermarketbeat.com - December 16 at 3:33 PMMolecular Partners Presents New Preclinical Data Supporting its MP0533 DARPin T-Cell Engager for the Treatment of AMLfinance.yahoo.com - December 12 at 9:41 PMMolecular Partners AG's (VTX:MOLN) Stock's On An Uptrend: Are Strong Financials Guiding The Market?finance.yahoo.com - December 2 at 4:40 AMFY2023 EPS Estimates for Molecular Partners AG (NASDAQ:MOLN) Cut by Analystmarketbeat.com - November 28 at 1:44 AM Get Molecular Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for MOLN and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> MOLN Media Mentions By Week MOLN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MOLN News Sentiment▼0.380.41▲Average Medical News Sentiment MOLN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MOLN Articles This Week▼10▲MOLN Articles Average Week Get Molecular Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for MOLN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cellectis News Today DBV Technologies News Today Omega Therapeutics News Today Agenus News Today Zura Bio News Today Vaxart News Today Karyopharm Therapeutics News Today BioAtla News Today INmune Bio News Today LENZ Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MOLN) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Molecular Partners AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
